Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

Spremljeno u:
Bibliografski detalji
Izdano u:Haematologica
Glavni autori: Zwaginga, Jaap J., van der Holt, Bronno, te Boekhorst, Peter A., Biemond, Bart J., Levin, Mark-David, van der Griend, René, Brand, Anneke, Zweegman, Sonja, Pruijt, Hans F.M., Novotny, Vera M.J., Vreugdenhil, Art, de Groot, Marco R., de Weerdt, Okke, van Pampus, Elisabeth C.M., van Maanen-Lamme, Tanja M., Wittebol, Shulamiet, Schipperus, Martin R., Silbermann, Matthijs H., Huijgens, Peter C., Luten, Marleen, Hollestein, Rene, Brakenhoff, Jan A.C., Schrama, Jolanda G., Valster, Fransje A.A., Velders, Gerjo A., Koene, Harry R.
Format: Artigo
Jezik:Inglês
Izdano: Ferrata Storti Foundation 2015
Teme:
Online Only Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349285/
https://ncbi.nlm.nih.gov/pubmed/25425692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.110213
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items